<DOC>
	<DOCNO>NCT01102140</DOCNO>
	<brief_summary>This blind , control study examine impact pomegranate polyphenol extract ( POMx , Pom Wonderful , LLC ) , 1000mg cardiomyopathy subject chronic renal insufficiency .</brief_summary>
	<brief_title>The Impact Pomegranate Extract Chronic Cardiomyopathy Complicated Renal Insufficiency ( ImPrOVE ) : Pilot Study</brief_title>
	<detailed_description>Heart failure ( HF ) disease great prevalence U.S. associate high morbidity mortality . In individual concomitant chronic renal insufficiency ( CRI ) , outcomes even bad due pharmaceutical treatment high baseline level oxidative stress . Reactive oxygen specie ( ROS ) generate mechanoenergetic uncoupling cause myocardial protein , lipid , DNA damage , lead development HF . One mean prevent progression HF may ROS reduction improvement systemic local oxidative stress handling . In randomized , single blind placebo-controlled pilot study , hypothesize 12 week treatment oral pomegranate extract ( POMx ) lead reduction oxidative stress ( assessed measure thiobarbituric acid-reactive substance , F8-isoprostanes , glutathione ) subject ( n=30 ) cardiomyopathy ( LVEF ≤40 % ) CRI ( GFR &lt; 60 ml/hr ) . Secondary aim include assess impact POMx myocardial remodel endothelial dysfunction measure serum collagen level asymmetric dimethylarginine , respectively . Findings study serve pilot data large randomize trial long term POMx therapy subject cardiomyopathy .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Adult subject ( ≥21 year age ) cardiomyopathy ( ejection fraction ≤40 % ) least 1 year duration CRI ( GFR &lt; 60 cc/hr least 3 month ) eligible enrollment . Subjects must New York Heart Association ( NYHA ) functional class IIII symptom stable dos HF evidencebased therapy ( βblocker , ACE inhibitor ARBs , aldosterone inhibitor [ appropriate ] ) least 3 month document contraindication intolerance therapy Subjects admit hospital acute myocardial infarction ( define positive troponins ) HF exacerbation within last 6 month eligible enrollment . Subjects warfarin rosuvastatin also exclude . Other exclusion criterion follow : HF deem congenital infiltrative etiology presence lifethreatening illness project survival ≤6 month ; ongoing infection pregnancy inability followup endstage renal disease require dialysis renal transplant listing recent ( within last 6 month ) POMx use intake &gt; 8 ounce daily pomegranate juice know hypersensitivity fruit Punicaceae family connective tissue collagen vascular disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Cardiomyopathy</keyword>
	<keyword>Heart Failure</keyword>
</DOC>